XML 43 R2.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Statements of Operations - USD ($)
shares in Millions
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Income Statement [Abstract]      
Net operating revenues $ 4,605,000,000.0 $ 4,277,300,000 $ 3,913,900,000
Operating expenses:      
Salaries and benefits 2,573,000,000.0 2,354,000,000.0 2,154,600,000
Other operating expenses 623,600,000 585,100,000 531,600,000
Occupancy costs 82,300,000 78,000,000.0 73,500,000
Supplies 167,900,000 158,700,000 149,300,000
General and administrative expenses 247,000,000.0 220,200,000 171,700,000
Depreciation and amortization 218,700,000 199,700,000 183,800,000
Government, class action, and related settlements 0 52,000,000.0 0
Total operating expenses 3,912,500,000 3,647,700,000 3,264,500,000
Loss on early extinguishment of debt 7,700,000 0 10,700,000
Interest expense and amortization of debt discounts and fees 159,700,000 147,300,000 154,400,000
Other income (30,500,000) (2,200,000) (4,100,000)
Equity in net income of nonconsolidated affiliates (6,700,000) (8,700,000) (8,000,000.0)
Income from continuing operations before income tax expense 562,300,000 493,200,000 496,400,000
Provision for income tax expense 115,900,000 118,900,000 145,800,000
Income from continuing operations 446,400,000 374,300,000 350,600,000
(Loss) income from discontinued operations, net of tax (600,000) 1,100,000 (400,000)
Net income 445,800,000 375,400,000 350,200,000
Less: Net income attributable to noncontrolling interests (87,100,000) (83,100,000) (79,100,000)
Net income attributable to Encompass Health $ 358,700,000 $ 292,300,000 $ 271,100,000
Weighted average common shares outstanding:      
Basic (shares) 98.0 97.9 93.7
Diluted (shares) 99.4 99.8 99.3
Basic earnings per share attributable to Encompass Health common shareholders:      
Continuing operations (in dollars per share) $ 3.66 $ 2.97 $ 2.88
Discontinued operations (in dollars per share) (0.01) 0.01 0
Net income (in dollars per share) 3.65 2.98 2.88
Diluted earnings per share attributable to Encompass Health common shareholders:      
Continuing operations (in dollars per share) 3.62 2.92 2.84
Discontinued operations (in dollars per share) (0.01) 0.01 0
Net income (in dollars per share) $ 3.61 $ 2.93 $ 2.84
Amounts attributable to Encompass Health:      
Income from continuing operations $ 359,300,000 $ 291,200,000 $ 271,500,000
(Loss) income from discontinued operations, net of tax (600,000) 1,100,000 (400,000)
Net income attributable to Encompass Health $ 358,700,000 $ 292,300,000 $ 271,100,000